Gerresheimer AG (GXI.DE)
EUR 75.75
(-3.13%)
EUR 75.75
(-3.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.99 Billion | 1.81 Billion | 1.49 Billion | 1.41 Billion | 1.39 Billion | 1.36 Billion |
| Cost of Revenue | 1.39 Billion | 1.27 Billion | 1.05 Billion | 981.18 Million | 1.11 Billion | 967.59 Million |
| Gross Profit | 597.31 Million | 546.81 Million | 442.22 Million | 437.6 Million | 277.18 Million | 400.13 Million |
| Operating Expenses | 383.92 Million | 327.51 Million | 263.39 Million | 257.67 Million | 244.56 Million | 244.31 Million |
| Selling, General and Administrative Expenses | 372.62 Million | 304.63 Million | 247.1 Million | 232.51 Million | 233.29 Million | 259.4 Million |
| Research and Development Expenses | 18.96 Million | 21.61 Million | 10 Million | 7.65 Million | 3.59 Million | 2.91 Million |
| Other Expenses | -7.66 Million | 1.25 Million | 6.28 Million | 17.5 Million | 7.68 Million | 4.68 Million |
| Cost and Expenses | 1.77 Billion | 1.59 Billion | 1.31 Billion | 1.23 Billion | 1.35 Billion | 1.21 Billion |
| Operating Income | 213.39 Million | 169.31 Million | 147.44 Million | 156.46 Million | 26.71 Million | 139.45 Million |
| Interest Expense | 50.43 Million | 27.95 Million | 20.7 Million | 20.76 Million | 24.7 Million | 29.74 Million |
| Income Tax Expense | 47.34 Million | 38.62 Million | 40.62 Million | 45.26 Million | 15.48 Million | -23.93 Million |
| Earnings before Tax | 167.42 Million | 140.81 Million | 127.86 Million | 135.14 Million | 98.16 Million | 107.19 Million |
| Net Income | 116.12 Million | 96.12 Million | 83.78 Million | 88.55 Million | 80.78 Million | 128.96 Million |
| Earnings Per Share Basic | 3.48 | 3.06 | 2.67 | 2.82 | 2.57 | 4.11 |
| Earnings Per Share Diluted | 3.48 | 3.06 | 2.67 | 2.82 | 2.57 | 4.11 |
| Weighted Average Shares Outstanding | 33.33 Million | 31.4 Million | 31.4 Million | 31.4 Million | 31.4 Million | 31.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.33 Million | 31.4 Million | 31.4 Million | 31.4 Million | 31.4 Million | 31.4 Million |
| Gross Margin | 0.30 | 0.30 | 0.30 | 0.31 | 0.20 | 0.29 |
| EBIT Margin | 0.20 | 0.21 | 0.22 | 0.23 | 0.21 | 0.21 |
| Profit Margin | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 | 0.09 |
| EBITDA | 400.56 Million | 340.19 Million | 293.09 Million | 309.25 Million | 279.55 Million | 274.3 Million |
| Earnings Before Tax Margin | 0.11 | 0.09 | 0.10 | 0.11 | 0.02 | 0.10 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 498.51 Million | 502.37 Million | 466.13 Million | 1.99 Billion | 545.17 Million | 487.94 Million |
| Cost of Revenue | 350.67 Million | 353.72 Million | 336.54 Million | 1.39 Billion | 385.85 Million | 338.1 Million |
| Gross Profit | 147.83 Million | 148.65 Million | 129.59 Million | 597.31 Million | 159.31 Million | 149.83 Million |
| Operating Expenses | 99.45 Million | 89.31 Million | 97.7 Million | 367.85 Million | 74.14 Million | 96.22 Million |
| Selling, General and Administrative Expenses | 95.08 Million | 84.16 Million | 93.24 Million | - | 39.44 Million | 95.91 Million |
| Research and Development Expenses | 4.76 Million | 5.15 Million | 5.56 Million | - | 3.58 Million | 1.03 Million |
| Other Expenses | -393 Thousand | -5.39 Million | - | 5.4 Million | - | - |
| Cost and Expenses | 450.13 Million | 443.03 Million | 434.25 Million | 1.76 Billion | 459.99 Million | 434.33 Million |
| Operating Income | 48.38 Million | 59.34 Million | 31.88 Million | 213.39 Million | 69.1 Million | 53.6 Million |
| Interest Expense | 15.45 Million | 14.3 Million | 13.39 Million | 50.43 Million | 12.72 Million | 12.94 Million |
| Income Tax Expense | 7.48 Million | 10.8 Million | 6.91 Million | 47.34 Million | 15.62 Million | 13.4 Million |
| Earnings before Tax | 35.15 Million | 43.73 Million | 20.34 Million | 167.42 Million | 57.9 Million | 42.13 Million |
| Net Income | 27.2 Million | 32.46 Million | 13 Million | 116.12 Million | 41.61 Million | 28.02 Million |
| Earnings Per Share Basic | 0.79 | 0.94 | 0.38 | - | 1.20 | 0.81 |
| Earnings Per Share Diluted | 0.79 | 0.94 | 0.38 | - | 1.20 | 0.81 |
| Weighted Average Shares Outstanding | 34.54 Million | 34.54 Million | 34.54 Million | 33.33 Million | 34.54 Million | 34.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.54 Million | 34.54 Million | 34.54 Million | 33.33 Million | 34.54 Million | 34.54 Million |
| Gross Margin | 0.30 | 0.30 | 0.28 | 0.30 | 0.29 | 0.31 |
| EBIT Margin | 0.20 | 0.19 | 0.17 | - | 0.22 | 0.21 |
| Profit Margin | 0.05 | 0.06 | 0.03 | 0.06 | 0.08 | 0.06 |
| EBITDA | 101.02 Million | 97.31 Million | 81.17 Million | - | 118.43 Million | 100.44 Million |
| Earnings Before Tax Margin | 0.10 | 0.12 | 0.07 | 0.11 | 0.13 | 0.11 |
MKKGY
CJR-B
3154
7965
0HOH
BIOEX